Exane Derivatives’s Teladoc Health TDOC Stock Holding History

Exane Derivatives’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,659	Closed	-$336K	–	918
2022 Q1	$336K	Buy	+4,659	New	+$336K	0.09%	235
2021 Q4	–	Sell	-4,769	Closed	-$605K	–	968
2021 Q3	$605K	Buy	4,769 +413	+9%	+$60.1K	0.15%	151
2021 Q2	$672K	Buy	4,356 +2,617	+150%	+$424K	0.15%	135
2021 Q1	$316K	Sell	1,739 -1,824	-51%	-$423K	0.09%	210
2020 Q4	$712K	Buy	3,563 +1,564	+78%	+$318K	0.21%	108
2020 Q3	$438K	Buy	+1,999	New	+$423K	0.13%	146

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Exane Derivatives's TDOC Position: Q2 2022 in Review

Exane Derivatives sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,659 shares — an estimated $336K sold.

Exane Derivatives first reported a position in TDOC in Q3 2020 and held it in 6 quarters. The position peaked at $712K in Q4 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Exane Derivatives reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 4,659 Teladoc Health shares in Q2 2022, an estimated $336K.
Exane Derivatives first reported a position in Teladoc Health in Q3 2020 and held it in 6 quarters.
Exane Derivatives's Teladoc Health position peaked at $712K in Q4 2020.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.